Natural Capsules Ltd. (NATCAPSUQ) Share Price Falls 8.15% as Micro Cap Stock Clears Threshold

Natural Capsules Ltd. Share Price fell to Rs 147, down 8.15% today, taking the Healthcare micro cap’s market capitalisation to Rs 172.98 crore.

Natural Capsules Ltd. Share Price fell to Rs 147 on 13 August 2026, down 8.15% from the previous close of Rs 160.05, putting the stock among the top decliner names being tracked in today’s Stock Market Today moves. With a market capitalisation of Rs 172.98 crore, Natural Capsules Ltd. Share Price Today also became notable because the stock is classified in the Micro Cap category and its single-day share price decline cleared the exact 8.15% move that qualified it under the event filter tied to its market-cap bucket.

The verified data confirms the price event, the magnitude of the fall and the trading pattern, but it does not establish a company-specific catalyst behind why the stock is falling today. That distinction matters for anyone following Natural Capsules Ltd. Stock News, because a sharp intraday decline can draw attention even when no confirmed trigger is available in the supplied data.

For investors monitoring Natural Capsules Ltd. Share Price, the important near-term facts are clear. The stock opened at Rs 159.8, failed to move above that level, and fell to a day low of Rs 147, which also matched the current price at the time of the event snapshot. Total traded volume stood at 46,636 shares across exchanges, including 7,936 shares on BSE and 38,700 shares on NSE, while turnover was Rs 0.12 crore. From a financial-analysis perspective, the stock trades at a P/B ratio of 0.76, a P/E ratio of -6.21, ROE of 19.18 and ROCE of 20.75. Univest notes that investors should now watch whether the price fall remains an isolated price action event or becomes part of a broader trend in Natural Capsules Ltd. Share Price News.

Natural Capsules Ltd. (NATCAPSUQ) Share Price Today: Price Action Analysis

Natural Capsules Ltd. (NATCAPSUQ) traded at Rs 147. versus the previous close of Rs 160.05, a fall of 8.15%. The stock opened at Rs 159.8, reached Rs 159.8, touched Rs 147. Reported volume was 7,936.

Natural Capsules Ltd. (NATCAPSUQ) Fundamental Analysis

Natural Capsules Ltd. was valued at a P/E ratio of -6.21x, a P/B ratio of 0.76x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 19.18% and ROCE of 20.75%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs -23.69, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Natural Capsules Ltd. Fundamental Analysis starts with an unusual combination of valuation and profitability numbers. The company’s market capitalisation stands at Rs 172.98 crore, placing it in the micro cap segment, while its P/E ratio is -6.21 and P/B ratio is 0.76. A negative P/E ratio indicates reported earnings on the denominator are negative, which is consistent with the supplied EPS of -23.69. EPS shows earnings attributable to each share, so a negative EPS means the current earnings figure embedded in the ratio remains in loss territory.

At the same time, Natural Capsules Ltd. Share Price is trading at 0.The P/B ratio matters because it compares the stock price with the accounting net worth behind each share. A sub-1 multiple can attract attention in Stock Analysis discussions, but valuation interpretation must still be anchored to the broader profitability and sector context rather than the ratio alone.

The return ratios supplied with Natural Capsules Ltd. Stock News are stronger than the P/E headline might suggest. ROE is 19.18, and ROCE is 20.75. ROE measures return generated on shareholder equity, while ROCE measures returns on capital employed. Both figures are meaningful because they show the business has posted double-digit return ratios despite the current negative earnings per share figure. That makes Natural Capsules Ltd. Share Price News more nuanced than a simple “cheap” or “expensive” label.

Dividend yield is 0, which means the supplied data does not point to a current historical payout relative to the stock price. For investors tracking Natural Capsules Ltd. Financial Results and Natural Capsules Ltd. Earnings through a market lens, the main takeaway from Univest is that the stock combines a negative P/E and negative EPS with a relatively low P/B and solid ROE and ROCE. That mix does not produce a one-line verdict, but it does explain why the counter can remain on the watchlist after a sharp share price fall. The next logical step is to compare these metrics with the wider Pharmaceuticals & Drugs industry and then with listed peers.

Sector and Industry Context

Natural Capsules Ltd. (NATCAPSUQ) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Natural Capsules Ltd. (NATCAPSUQ) has a P/E ratio of -6.21x, which is below the benchmark median of 25.27x, a difference of -124.57%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Natural Capsules Ltd. (NATCAPSUQ) has a ROE of 19.18%, which is above the benchmark median of 10.49%, a difference of +82.84%. Natural Capsules Ltd. (NATCAPSUQ) has a ROCE of 20.75%, which is above the benchmark median of 12.97%, a difference of +59.98%.

Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Natural Capsules Ltd. Share Price sits within the Healthcare sector and the Pharmaceuticals & Drugs industry, and the supplied benchmark provides a useful same-industry comparison across 136 companies. The most important sector takeaway is that the company’s valuation and return profile look meaningfully different from the broader industry median, even though today’s price fall has put near-term price action under pressure.

Within the same industry benchmark of 136 companies, Natural Capsules Ltd. has a company P/E of -6.21. That compares with a median P/E of 25.27, an average P/E of 69.01, a minimum of 3.44 and a maximum of 3374.81 across 103 companies with P/E data. On this dataset, Natural Capsules Ltd. Share Price is clearly not trading anywhere near the industry’s typical positive earnings multiple because its P/E remains negative.

The valuation picture on price to book looks different. Natural Capsules Ltd. has a company P/B of 0.76, versus a benchmark median of 1.82 and an average of 2.44 across 135 companies, with a range from -16.89 to 16.74. On that measure, Natural Capsules Ltd. Share Price appears below both the industry median and average. Profitability metrics are stronger relative to the benchmark. Company ROE stands at 19.18 against a median of 10.49 and an average of 8.09, while company ROCE is 20.75 against a median of 12.97 and an average of 15.63. That places its return ratios above both the benchmark median and average in the supplied same-industry set.

Market-cap context also matters in Natural Capsules Ltd. Market Cap analysis. The company’s market capitalisation of Rs 172.98 crore is above the industry median of Rs 147.59 crore but well below the average of Rs 490.67 crore, reflecting how larger companies lift the mean. Univest reads this as a stock with smaller size, lower price-to-book valuation and stronger return ratios than industry central tendencies, but with a negative P/E that keeps the fundamental picture mixed rather than straightforward.

Peer Comparison

Natural Capsules Ltd. (NATCAPSUQ) has a P/E ratio of -6.21x compared with the displayed peer median of 44.25x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.18% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 20.75% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Natural Capsules Ltd. (NATCAPSUQ) has a market capitalisation of Rs 172.98 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Natural Capsules Ltd. Share Price becomes more interesting when placed beside listed Pharmaceuticals & Drugs peers supplied in the dataset. The peer list ranges from Dishman Carbogen Amcis Ltd. at Rs 3,027.48 crore market cap to Hester Biosciences Ltd. at Rs 2,112.08 crore, which immediately shows the scale gap: Natural Capsules Ltd., at Rs 172.98 crore, is much smaller than all named peers in this comparison set.

On valuation, Natural Capsules Ltd. carries a P/B ratio of 0.76. That is close to Dishman Carbogen Amcis Ltd. at 0.77 and below Ind-Swift Laboratories Ltd. at 1.76, Hikal Ltd. at 2.2, Solara Active Pharma Sciences Ltd. at 1.91, Hester Biosciences Ltd. at 4.59, Sakar Healthcare Ltd. at 6.22, NGL Fine-Chem Ltd. at 6.4, Panacea Biotec Ltd. at 8.59 and Beta Drugs Ltd. at 10.82. From a pure book-value multiple perspective, Natural Capsules Ltd. Share Price is positioned at the low end of the peer set.

Profitability presents a more balanced picture. Natural Capsules Ltd. reports ROE of 19.18, which is above Hikal at 15.22, Sai Parenteral’s at 13.9, Sakar Healthcare at 11.88, Hester Biosciences at 16.17, Solara at 17.23, Panacea Biotec at 0 and Dishman Carbogen Amcis at -2.89, while it is slightly above Beta Drugs at 18.65 and below NGL Fine-Chem at 27.9. ROCE at 20.75 is above Hikal at 16.15, Solara at 15.34, Sai Parenteral’s at 12.97, Sakar Healthcare at 13.16, Hester Biosciences at 14.12, Ind-Swift Laboratories at 8.31, Panacea Biotec at 5.36 and Dishman Carbogen Amcis at -0.26, while it trails NGL Fine-Chem at 33.91 and Beta Drugs at 22.17.

Where peer comparison gets complicated is P/E. Several peers trade on positive multiples such as Beta Drugs at 68.39, Sai Parenteral’s at 171.25, Ind-Swift Laboratories at 44.25, NGL Fine-Chem at 43.8, Hester Biosciences at 15.32 and Sakar Healthcare at 57.68, whereas Natural Capsules Ltd. stands at -6.21. So, Univest would characterise the peer picture as low P/B, strong return ratios relative to many peers, but an earnings multiple that remains structurally different because of the negative denominator.

Why Investors Are Watching Natural Capsules Ltd.

Natural Capsules Ltd. Share Price is drawing attention because today’s move was large enough to clear its event threshold, while the stock’s underlying metrics do not fit into a simple one-way narrative. The session featured a sharp price fall, but the broader data also shows low price-to-book valuation and return ratios that compare well against much of the same-industry benchmark. That combination keeps the stock relevant in Stocks in News, Top Losers Today and Market Movers discussions.

• Price action: Natural Capsules Ltd. Share Price fell 8.15% to Rs 147 from the previous close of Rs 160.05.
• Intraday structure: The stock opened at Rs 159.8, which was also the day high, and then fell to the day low of Rs 147.
• Event relevance:< 15%.
• Trading activity: Total volume was 46,636 shares, including 7,936 on BSE and 38,700 on NSE, with turnover of Rs 0.12 crore.
• Fundamental context: P/E is -6.21, P/B is 0.76, ROE is 19.18, ROCE is 20.75 and EPS is -23.69.
• Sector positioning: ROE and ROCE are above same-industry medians, while P/B is below the industry median.